Search

Your search keyword '"Visentin, Andrea"' showing total 14 results
Start Over Author "Visentin, Andrea" Journal haematologica
14 results on '"Visentin, Andrea"'

1. A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report

Author

Elice, Francesca, primary, Sommaggio, Roberta, additional, Cappuzzello, Elisa, additional, Riva, Marcello, additional, Tisi, Maria Chiara, additional, Bernardi, Martina, additional, Bozza, Angela, additional, Catanzaro, Daniela, additional, Chieregato, Katia, additional, Merlo, Anna, additional, Giaretta, Ilaria, additional, Pieta, Anna Dalla, additional, Krampera, Mauro, additional, Visco, Carlo, additional, Trentin, Livio, additional, Visentin, Andrea, additional, Tosetto, Alberto, additional, Astori, Giuseppe, additional, and Rosato, Antonio, additional

Published
2024
Full Text
View/download PDF

2. High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 – VERITAS study

Author

Mauro, Francesca R., primary, Starza, Irene Della, additional, Messina, Monica, additional, Reda, Gianluigi, additional, Trentin, Livio, additional, Coscia, Marta, additional, Sportoletti, Paolo, additional, Orsucci, Lorella, additional, Arena, Valentina, additional, Casaluci, Gloria Margiotta, additional, Marasca, Roberto, additional, Murru, Roberta, additional, Laurenti, Luca, additional, Ilariucci, Fiorella, additional, Stelitano, Caterina, additional, Mannina, Donato, additional, Massaia, Massimo, additional, Rigolin, Gian Matteo, additional, Scarfò, Lydia, additional, Marchetti, Monia, additional, Levato, Luciano, additional, Tani, Monica, additional, Arcari, Annalisa, additional, Musuraca, Gerardo, additional, Deodato, Marina, additional, Galieni, Piero, additional, Patrizi, Valeria Belsito, additional, Gottardi, Daniela, additional, Liberati, Anna Marina, additional, Giordano, Annamaria, additional, Molinari, Maria Chiara, additional, Pietrasanta, Daniela, additional, Mattiello, Veronica, additional, Visentin, Andrea, additional, Vitale, Candida, additional, Albano, Francesco, additional, Neri, Antonino, additional, De Novi, Lucia Anna, additional, De Propris, Maria Stefania, additional, Nanni, Mauro, additional, Del Giudice, Ilaria, additional, Guarini, Anna, additional, Fazi, Paola, additional, Vignetti, Marco, additional, Piciocchi, Alfonso, additional, Cuneo, Antonio, additional, and Foà, Robin, additional

Published
2023
Full Text
View/download PDF

3. Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study

Author

Innocenti, Idanna, primary, Reda, Gianluigi, additional, Visentin, Andrea, additional, Coscia, Marta, additional, Motta, Marina, additional, Murru, Roberta, additional, Moia, Riccardo, additional, Gentile, Massimo, additional, Pennese, Elsa, additional, Quaglia, Francesca Maria, additional, Albano, Francesco, additional, Cassin, Ramona, additional, Deodato, Marina, additional, Ielo, Claudia, additional, Frustaci, Anna Maria, additional, Piciocchi, Alfonso, additional, Rughini, Arianna, additional, Arena, Valentina, additional, Di Sevo, Daniela, additional, Tomasso, Annamaria, additional, Autore, Francesco, additional, Del Poeta, Giovanni, additional, Scarfò, Lydia, additional, Mauro, Francesca Romana, additional, Tedeschi, Alessandra, additional, Trentin, Livio, additional, Pompili, Maurizio, additional, Foà, Robin, additional, Ghia, Paolo, additional, Cuneo, Antonio, additional, and Laurenti, Luca, additional

Published
2022
Full Text
View/download PDF

5. The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation

Author

Visentin, Andrea, primary, Bonaldi, Laura, additional, Rigolin, Gian Matteo, additional, Mauro, Francesca Romana, additional, Martines, Annalisa, additional, Frezzato, Federica, additional, Pravato, Stefano, additional, Gargarella, Leila Romano, additional, Bardi, Maria Antonella, additional, Cavallari, Maurizio, additional, Volta, Eleonora, additional, Cavazzini, Francesco, additional, Nanni, Mauro, additional, Facco, Monica, additional, Piazza, Francesco, additional, Guarini, Anna, additional, Foà, Robin, additional, Semenzato, Gianpietro, additional, Cuneo, Antonio, additional, and Trentin, Livio, additional

Published
2021
Full Text
View/download PDF

6. p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape

Author

Patrussi, Laura, primary, Capitani, Nagaja, additional, Ulivieri, Cristina, additional, Manganaro, Noemi, additional, Granai, Massimo, additional, Cattaneo, Francesca, additional, Kabanova, Anna, additional, Mundo, Lucia, additional, Gobessi, Stefania, additional, Frezzato, Federica, additional, Visentin, Andrea, additional, Finetti, Francesca, additional, Pelicci, Pier Giuseppe, additional, D’Elios, Mario M., additional, Trentin, Livio, additional, Semenzato, Gianpietro, additional, Leoncini, Lorenzo, additional, Efremov, Dimitar G., additional, and Baldari, Cosima T., additional

Published
2019
Full Text
View/download PDF

7. Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells

Author

Tibaldi, Elena, primary, Pagano, Mario Angelo, additional, Frezzato, Federica, additional, Trimarco, Valentina, additional, Facco, Monica, additional, Zagotto, Giuseppe, additional, Ribaudo, Giovanni, additional, Pavan, Valeria, additional, Bordin, Luciana, additional, Visentin, Andrea, additional, Zonta, Francesca, additional, Semenzato, Gianpietro, additional, Brunati, Anna Maria, additional, and Trentin, Livio, additional

Published
2017
Full Text
View/download PDF

10. A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokineinduced killer cells: a first-in-human case report.

Author

Elice F, Sommaggio R, Cappuzzello E, Riva M, Tisi MC, Bernardi M, Bozza A, Catanzaro D, Chieregato K, Merlo A, Giaretta I, Pieta AD, Krampera M, Visco C, Trentin L, Visentin A, Tosetto A, Astori G, and Rosato A

Subjects
Humans, Male, Killer Cells, Natural immunology, Killer Cells, Natural drug effects, Treatment Outcome, Antineoplastic Agents, Immunological therapeutic use, Antineoplastic Agents, Immunological administration & dosage, Middle Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Drug Resistance, Neoplasm, Antibodies, Monoclonal, Humanized therapeutic use, Antibodies, Monoclonal, Humanized administration & dosage, Lymphoma, Large B-Cell, Diffuse drug therapy, Lymphoma, Large B-Cell, Diffuse therapy, Lymphoma, Large B-Cell, Diffuse pathology
Published
2024
Full Text
View/download PDF

12. The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation.

Author

Visentin A, Bonaldi L, Rigolin GM, Mauro FR, Martines A, Frezzato F, Pravato S, Gargarella LR, Bardi MA, Cavallari M, Volta E, Cavazzini F, Nanni M, Facco M, Piazza F, Guarini A, Foà R, Semenzato G, Cuneo A, and Trentin L

Subjects
Humans, Karyotype, Mutation, Retrospective Studies, Leukemia, Lymphocytic, Chronic, B-Cell diagnosis, Leukemia, Lymphocytic, Chronic, B-Cell genetics, Lymphoma, Large B-Cell, Diffuse
Abstract

Complex karyotype (CK) at chronic lymphocytic leukemia (CLL) diagnosis is a negative biomarker of adverse outcome. Since the impact of CK and its subtypes, namely type-2 CK (CK with major structural abnormalities) or high-CK (CK with ≥5 chromosome abnormalities), on the risk of developing Richter syndrome (RS) is unknown, we carried out a multicenter real-life retrospective study to test its prognostic impact. Among 540 CLL patients, 107 harbored a CK at CLL diagnosis, 78 were classified as CK2 and 52 as high-CK. Twenty-eight patients developed RS during a median follow-up of 6.7 years. At the time of CLL diagnosis, CK2 and high-CK were more common and predicted the highest risk of RS transformation, together with advanced Binet stage, unmutated (U)-IGHV, 11q-, and TP53 abnormalities. We integrated these variables into a hierarchical model: high-CK and/or CK2 patients showed a 10-year time to RS (TTRS) of 31%; U-IGHV/11q- /TP53 abnormalities/Binet stage B-C patients had a 10-year TTRS of 12%; mutated (M)-IGHV without CK and TP53 disruption a 10-year TTRS of 3% (P<0.0001). We herein demonstrate that CK landscape at CLL diagnosis allows the risk of RS transformation to be refined and we recapitulated clinico-biological variables into a prognostic model.

Published
2022
Full Text
View/download PDF

13. Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients.

Author

Briani C, Visentin A, Salvalaggio A, Imbergamo S, Piazza F, Cacciavillani M, Campagnolo M, Frezzato F, Semenzato G, and Trentin L

Subjects
ADP-ribosyl Cyclase 1 genetics, ADP-ribosyl Cyclase 1 metabolism, Aged, Female, Humans, Immunoglobulin Heavy Chains genetics, Immunoglobulin Heavy Chains metabolism, Immunoglobulin Variable Region genetics, Immunoglobulin Variable Region metabolism, Leukemia, Lymphocytic, Chronic, B-Cell complications, Leukemia, Lymphocytic, Chronic, B-Cell mortality, Longitudinal Studies, Male, Membrane Glycoproteins genetics, Membrane Glycoproteins metabolism, Middle Aged, Mutation, Peripheral Nervous System Diseases complications, Peripheral Nervous System Diseases mortality, Survival Analysis, Time Factors, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, ZAP-70 Protein-Tyrosine Kinase genetics, ZAP-70 Protein-Tyrosine Kinase metabolism, Gene Expression Regulation, Leukemic, Leukemia, Lymphocytic, Chronic, B-Cell genetics, Leukemia, Lymphocytic, Chronic, B-Cell pathology, Peripheral Nervous System Diseases genetics, Peripheral Nervous System Diseases pathology
Published
2017
Full Text
View/download PDF

14. Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy.

Author

Visentin A, Compagno N, Cinetto F, Imbergamo S, Zambello R, Piazza F, Semenzato G, Trentin L, and Agostini C

Subjects
Aged, Aged, 80 and over, Female, Humans, Infections etiology, Infections microbiology, Infections mortality, Leukemia, Lymphocytic, Chronic, B-Cell microbiology, Leukemia, Lymphocytic, Chronic, B-Cell mortality, Male, Middle Aged, Immunoglobulins, Intravenous administration & dosage, Infections drug therapy, Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results